您的位置: 专家智库 > >

国家自然科学基金(30670921)

作品数:3 被引量:13H指数:1
相关作者:王柏丁文富强宁允叶李继琼韩素霞更多>>
相关机构:四川大学新疆医科大学第五附属医院华西医科大学更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生生物学更多>>

文献类型

  • 3篇中文期刊文章

领域

  • 2篇医药卫生
  • 1篇生物学

主题

  • 2篇细胞
  • 1篇蛋白
  • 1篇低氧
  • 1篇低氧诱导
  • 1篇低氧诱导因子
  • 1篇低氧诱导因子...
  • 1篇支气管
  • 1篇支气管上皮
  • 1篇支气管上皮细...
  • 1篇人支气管上皮
  • 1篇人支气管上皮...
  • 1篇上皮
  • 1篇上皮细胞
  • 1篇气管
  • 1篇气管上皮
  • 1篇气管上皮细胞
  • 1篇热休克
  • 1篇热休克蛋白
  • 1篇热休克蛋白7...
  • 1篇流式细胞

机构

  • 2篇四川大学
  • 1篇华西医科大学
  • 1篇四川大学华西...
  • 1篇四川工商职业...
  • 1篇新疆医科大学...

作者

  • 2篇宁允叶
  • 2篇文富强
  • 2篇王柏丁
  • 1篇冯玉麟
  • 1篇韩素霞
  • 1篇李继琼

传媒

  • 1篇中国癌症杂志
  • 1篇四川大学学报...
  • 1篇Chines...

年份

  • 2篇2009
  • 1篇2008
3 条 记 录,以下是 1-3
排序方式:
重组人activin A对A549细胞增殖及凋亡的影响
2009年
背景与目的:活化素(activins)是转化生长因子TGF-β超家族成员。有研究表明,活化素可以诱导多种肿瘤细胞的凋亡。本研究旨在探讨重组人activin A对人肺腺癌细胞系A549增殖及凋亡的影响。方法:体外培养A549细胞,以不同浓度activin A处理A549细胞不同时间后,用MTT法检测其生长抑制情况;流式细胞仪及Annexin V-FITC试剂盒检测activin A对A549细胞凋亡的影响;Western blot检测活化素Ⅱ型受体(ActRⅡ和ActRⅡB)的表达情况。结果:activin A能抑制A549细胞增殖,且呈剂量和时间依赖性。流式细胞仪检测结果显示,activin A能促进A549细胞凋亡。Western blot结果显示,随着activin A浓度的增加,活化素Ⅱ型受体的表达量呈浓度依赖性增加。结论:activin A能在体外抑制A549细胞的增殖并诱导其凋亡。推测是通过诱导活化素Ⅱ型受体的表达,激活其下游一系列信号转导通路,从而发挥其生物学功能。
王柏丁宁允叶冯玉麟文富强
关键词:ACTIVINA549流式细胞术
低氧对人支气管上皮细胞HSP70和HIF-1α表达的影响被引量:1
2009年
将人支气管上皮细胞(HBE)在低糖 DMEM 培养基、1%O_2培养不同时间后,分别用RT-PCR 和 Western blot 方法检测细胞 HSP70、HIF-1α的 mRNA 和蛋白表达水平,同时采用免疫组化技术观察低氧对 HSP70蛋白的影响.对照组培养于低糖、常氧条件下.结果表明,低氧条件下,HBE 细胞 HSP70 mRNA 和蛋白表达都有时间依赖性.在1h 时 HSP70mRNA转录水平即开始增加,与对照相比差异显著(P<0.05);在12h 时转录水平最高;而 HSP70蛋白的表达略有滞后,在3h 差异显著(P<0.05).低氧诱导因子 HIF-1αmRNA 水平在1h 时显著升高,在6h 和12h 时与对照相比差异极显著(P<0.01);HIF-1α蛋白的表达也同步增加,在6h 时达到峰值.这为慢性阻塞性肺疾病(COPD)的发病机制研究提供了一种可供选择的细胞模型.
宁允叶韩素霞王柏丁李继琼文富强
关键词:低氧人支气管上皮细胞热休克蛋白70低氧诱导因子-1Α
Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats被引量:12
2008年
Background Mucus hypersecretion in the respiratory tract and goblet cell metaplasia in the airway epithelium contribute to the morbidity and mortality associated with airway inflammatory diseases. This study aimed to examine the effect and mechanisms of simvastatin on airway mucus hypersecretion in rats treated with lipopolysaccharide (LPS). Methods Mucus hypersecretion in rat airways was induced by intra-tracheal instillation of LPS. Rats treated with or without LPS were administered intra-peritoneally simvastatin (5 and 20 mg/kg) for 4 days. Expression of Muc5ac, RhoA and mitogen-activated protein kinases (MAPK) p38 in lung were detected by real-time polymerase chain reaction (PCR), immunohistochemistry or Western blotting. Tumor necrosis factor (TNF)-α and IL-8 in bronchoalveolar lavage fluid (BALF) were assayed by an enzyme-linked lectin assay and enzyme linked immunosorbent assay (ELISA). Results Simvastatin attenuated LPS-induced goblet cell hyperplasia in bronchial epithelium and Muc5ac hypersecretion at both the gene and protein levels in lung (P 〈0.05). Moreover, simvastatin inhibited neutrophil accumulation and the increased concentration of TNF-α and IL-8 in BALF follows LPS stimulation (P 〈0.05). The higher dose of simvastatin was associated with a more significant reduction in Muc5ac mRNA expression, neutrophil accumulation and inflammatory cytokine release. Simultaneously, the increased expression of RhoA and p38 MAPK were observed in LPS-treated lung (P 〈0.05). Simvastatin inhibited the expression of RhoA and p38 phosphorylation in lung following LPS stimulation (P 〈0.05). However, the increased expression of p38 protein in LPS-treated lung was not affected by simvastatin administration. Conclusions Simvastatin attenuates airway mucus hypersecretion and pulmonary inflammatory damage induced by LPS. The inhibitory effect of simvastatin on airway mucus hypersecretion may be through, at least in part, the suppression of neutrophil accumulation and
OU Xue-mei WANG Bai-ding WEN Fu-qiang FENG Yu-lin HUANG Xiang-yang XIAO Jun
关键词:LIPOPOLYSACCHARIDESIMVASTATINRHOA
共1页<1>
聚类工具0